VOLUMEN 4 - NÚMERO 2 / Abril - Junio (Artículos originales / Original articles)
Sandra I. Rodríguez-Carranza, Endocrinology and Metabolism Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
Paloma Almeda-Valdés, Metabolic Diseases Research Unit, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City; Department of Endocrinology and Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City. Mexico
Nicole M. Iñiguez-Ariza, Endocrinology and Metabolism Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
Roberto Chavira, Biología de la Reproducción, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México
Francisco J. Gómez-Pérez, Departamento de Endocrinología y Metabolismo de Lípidos, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México
Macroprolactinemia is defined as the presence of prolactin with a molecular weight greater than 150 kDa. It can be confused with idiopathic hyperprolactinemia or with a prolactinoma. It is considered a benign variant and does not require medical treatment or follow-up. The objective of this article is to describe a series of patients with macroprolactinemia as a cause of hyperprolactinemia. Among fourteen cases, macroprolactinemia was found in eight (57.1%) and the majority (87.5%) presented with symptoms. Macroprolactinemia was frequent in this series of cases. The assessment of macroprolactinemia is useful in cases with apparently idiopathic hyperprolactinemia.
Palabras clave: Macroprolactinemia. Hyperprolactinemia. Prolactinoma.
Artículo completo en PDF